Php30 - The Contribution of New Product Entry vs Existing Product Inflation in the Rising Costs of Prescription Drugs in the United States

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.926
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Counting Housework: New Estimates of Real Product in the United States, 1800–1860

Journal of Economic History
HistoryEconomicsEconometricsFinance
1993English

Php32 - Impact of Manufacturer Competition on Prescription Drug Price Inflation in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Inflation Targeting in the United States?

2003English

Dairy Product Consumption and Prostate Cancer Risk in the United States

Nutrients
NutritionFood ScienceDietetics
2019English

Increasing Use of Prescription Drugs in the United Kingdom

Pharmacoepidemiology and Drug Safety
EpidemiologyPharmacology
2015English

Deregulating Direct‐to‐Consumer Marketing of Prescription Drugs: Effects on Prescription and Over‐the‐Counter Product Sales

Journal of Law and Economics
LawEconomicsEconometrics
2002English

Supply of Injectable Drugs for Individual Patients Using the Prescription Entry System. (I). Evaluation of the Prescription Entry System of Injectable Drugs.

Japanese Journal of Hospital Pharmacy
1996English

The Macroeconomic Implications of Rising Wage Inequality in the United States

Journal of Political Economy
EconomicsEconometrics
2010English

The Medical Costs of Gunshot Injuries in the United States

JAMA - Journal of the American Medical Association
Medicine
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy